SCHEMBL5762264

SCHEMBL5762264

O=S(=O)(C1=CCCC1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.50
FFAR2 O15552 1/20 0.39
PIK3CA P42336 2/20 0.39
ALDH1A1 P00352 4/20 0.39
LMNA P02545 3/20 0.39
TSHR P16473 3/20 0.39
THRB P10828 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GAA P10253 2/20 0.38
MCOLN3 Q8TDD5 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
HPGD P15428 1/20 0.38
PARL Q9H300 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA3 P07451 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10673707 0.94 HTR6 (0.48) HTR6FFAR2PIK3CAALDH1A1LMNA
SCHEMBL8989589 0.82 HSD11B1 (0.37) ALDH1A1
SCHEMBL19318751 0.81 GAA (0.54) FFAR2ALDH1A1GAACA12CA1
SCHEMBL7266457 0.76 LMNA (0.41) LMNAGAATDP1CA12CA1
SCHEMBL19318729 0.76 GAA (0.52) FFAR2ALDH1A1GAACA12CA1
SCHEMBL8031497 0.75 HSD11B1 (0.43) ALDH1A1TDP1
SCHEMBL16718944 0.74 GAA (0.50) FFAR2ALDH1A1TSHRGAAHSD17B10
SCHEMBL22548445 0.74 GAA (0.50) FFAR2ALDH1A1TSHRGAAHSD17B10
SCHEMBL11148487 0.73 HSD11B1 (0.46) ALDH1A1TDP1
(Phenylsulfonyl)Benzene SCHEMBL13735236 0.69 HTR6 (1.00) HTR6ALDH1A1TSHRHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014096374-A1 PROCESS FOR THE SYNTHESIS OF PYRROLIDINES AND PYRROLES SANDOZ AG (CH) 2014-06-26 WO disclosed
US-20060247286-A1 Oxazolidinone antibiotics and derivatives thereof KYORIN PHARMACEUTICAL CO., LTD. (JP) 2006-11-02 US disclosed
EP-1656357-A1 OXAZOLIDINONE ANTIBIOTICS AND DERIVATIVES THEREOF Merck & Co., Inc. (US) 2006-05-17 EP disclosed
WO-2005005399-A1 OXAZOLIDINONE ANTIBIOTICS AND DERIVATIVES THEREOF MERCK & CO., INC. (US) 2005-01-20 WO disclosed
EP-0819981-B1 Radiation sensitive resin composition JSR CORP (JP) 2002-06-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247286-A1 Oxazolidinone antibiotics and derivatives thereof OXA1L, RORC, IL17A HTR6 4743/4885FFAR2 1795/4885PIK3CA 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.